Slideshow Slideshow Slideshow Slideshow Slideshow Slideshow Slideshow Slideshow Slideshow Slideshow Slideshow Slideshow Slideshow Slideshow Slideshow Slideshow Slideshow
Fonds de recherche sur la santé

Nouvelles

59th European Association for the Study of Diabetes (EASD) Annual Meeting

19 octobre 2023

Capsules science 

Conference/publication date : 10/06/2023Congress venue/Author affiliation : Hamburg, GermanyName of presenter/author: Zekai Wu

Title of the article : Comparison of A First-Generation and A Second-Generation Commercial Automated Insulin Delivery (AID) in Glucose Management in Adults with Type 1 DiabetesTitle of the presentation/article : Comparison of A First-Generation and A Second-Generation Commercial Automated Insulin Delivery (AID) in Glucose Management in Adults with Type 1 Diabetes

Comparison between two commercial automated insulin delivery (AID) systems (Medtronic 670G/770G as a first-generation AID vs. Tandem Control-IQ as a second-generation AID with auto-correction feature) remains scarce. We conducted this post-hoc analysis of a prospective, observational, real-world study involving 52 adults with T1D (63% females). The findings suggested that compared with the first-generation AID system, the second-generation AID system achieved a higher time in range, mainly due to less time spent in hyperglycemia, among adults with type 1 diabetes in real-world settings. The benefits of less hyperglycemia may be mainly attributed to the auto-correction feature. This is the first study comparing two different brands of commercial AID systems.